BioNTech Investor
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Investors
.jpg)
Technology:
CAR-T, RNA
Industry:
CAR-T, RNA
Headquarters:
Mainz, Rheinland-Pfalz, Germany
Founded Date:
2008-01-01
Employees Number:
1001-5000
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
2
Investors Number:
16
Total Funding:
56080595
Estimated Revenue:
$100M to $500M
Last Funding Date:
2022-04-14
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership